{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:57:59Z","timestamp":1793879879328,"version":"4.7.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10238-020-00648-x","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T10:02:48Z","timestamp":1595844168000},"page":"493-506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":410,"title":["Organ-specific manifestations of COVID-19 infection"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6244-1229","authenticated-orcid":false,"given":"Maria","family":"Gavriatopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Korompoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Fotiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Ntanasis-Stathopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Psaltopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Kastritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meletios A.","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,27]]},"reference":[{"key":"648_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","volume":"17","author":"J Cui","year":"2019","unstructured":"Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181\u201392.","journal-title":"Nat Rev Microbiol"},{"key":"648_CR2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","volume":"14","author":"E de Wit","year":"2016","unstructured":"de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523\u201334.","journal-title":"Nat Rev Microbiol"},{"key":"648_CR3","doi-asserted-by":"crossref","unstructured":"Puelles VG, Lutgehetmann M, Lindenmeyer MT et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020.","DOI":"10.1056\/NEJMc2011400"},{"key":"648_CR4","doi-asserted-by":"crossref","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020.","DOI":"10.1001\/jama.2020.2648"},{"key":"648_CR5","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061\u20139.","journal-title":"JAMA"},{"key":"648_CR6","doi-asserted-by":"crossref","unstructured":"Goyal P, Choi JJ, Pinheiro LC et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020;382(24):2372\u20132374.","DOI":"10.1056\/NEJMc2010419"},{"key":"648_CR7","doi-asserted-by":"crossref","unstructured":"Bhatraju PK, Ghassemieh BJ, Nichols M et al. Covid-19 in critically ill patients in the Seattle region\u2014case series. N Engl J Med. 2020;382(21):2012\u20132022.","DOI":"10.1056\/NEJMoa2004500"},{"key":"648_CR8","doi-asserted-by":"crossref","unstructured":"Wang Y, Lu X, Chen H et al. Clinical course and outcomes of 344 intensive care patients with COVID-19. Am J Respir Crit Care Med. 2020.","DOI":"10.1164\/rccm.202003-0736LE"},{"key":"648_CR9","first-page":"e00127-00120","volume":"94","author":"Y Wan","year":"2020","unstructured":"Wan Y, Shang J, Graham R, et al. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020;94:e00127-00120.","journal-title":"J Virol"},{"key":"648_CR10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","volume":"581","author":"J Shang","year":"2020","unstructured":"Shang J, Ye G, Shi K, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581:221\u20134.","journal-title":"Nature"},{"key":"648_CR11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12026-014-8534-z","volume":"59","author":"R Channappanavar","year":"2014","unstructured":"Channappanavar R, Zhao J, Perlman S. T cell-mediated immune response to respiratory coronaviruses. Immunol Res. 2014;59:118\u201328.","journal-title":"Immunol Res"},{"key":"648_CR12","doi-asserted-by":"crossref","unstructured":"Huang SH. What we know so far (as of March 26, 2020) about COVID-19-an MRT point of view. J Med Imaging Radiat Sci. 2020;51(2):200\u2013203.","DOI":"10.1016\/j.jmir.2020.03.004"},{"key":"648_CR13","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","volume":"395","author":"H Li","year":"2020","unstructured":"Li H, Liu L, Zhang D, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020;395:1517\u201320.","journal-title":"Lancet"},{"key":"648_CR14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420\u20132.","journal-title":"Lancet Respir Med"},{"key":"648_CR15","doi-asserted-by":"crossref","unstructured":"Xu B, Fan CY, Wang AL et al. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China. J Infect. 2020;81(1):e51\u2013e60.","DOI":"10.1016\/j.jinf.2020.04.012"},{"key":"648_CR16","doi-asserted-by":"crossref","unstructured":"Zhou G, Chen S, Chen Z. Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies. Front Med. 2020;14(2):117\u2013125.","DOI":"10.1007\/s11684-020-0773-x"},{"key":"648_CR17","doi-asserted-by":"crossref","unstructured":"Buja LM, Wolf D, Zhao B et al. Emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): report of three autopsies from Houston, Texas and review of autopsy findings from other United States Cities. Cardiovasc Pathol. 2020; (published online).","DOI":"10.1016\/j.carpath.2020.107233"},{"key":"648_CR18","doi-asserted-by":"crossref","unstructured":"Barton LM, Duval EJ, Stroberg E et al. COVID-19 autopsies, Oklahoma, USA. Am J Clin Pathol. 2020;153(6):725\u2013733.","DOI":"10.1093\/ajcp\/aqaa062"},{"key":"648_CR19","doi-asserted-by":"crossref","unstructured":"McGonagle D, O\u2019Donnell JS, Sharif K et al. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet. 2020.","DOI":"10.1016\/S2665-9913(20)30121-1"},{"key":"648_CR20","doi-asserted-by":"crossref","unstructured":"Wolfel R, Corman VM, Guggemos W et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020.","DOI":"10.1038\/s41586-020-2984-3"},{"key":"648_CR21","doi-asserted-by":"crossref","first-page":"W85","DOI":"10.2214\/AJR.20.23035","volume":"214","author":"W Guan","year":"2020","unstructured":"Guan W, Liu J, Yu C. CT Findings of coronavirus disease (COVID-19) severe pneumonia. AJR Am J Roentgenol. 2020;214:W85\u20136.","journal-title":"AJR Am J Roentgenol"},{"key":"648_CR22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.34172\/aim.2020.11","volume":"23","author":"X Chen","year":"2020","unstructured":"Chen X, Liu S, Zhang C, et al. Dynamic chest CT evaluation in three cases of 2019 novel coronavirus pneumonia. Arch Iran Med. 2020;23:277\u201380.","journal-title":"Arch Iran Med"},{"key":"648_CR23","doi-asserted-by":"crossref","unstructured":"Huang G, Gong T, Wang G et al. Timely diagnosis and treatment shortens the time to resolution of coronavirus disease (COVID-19) pneumonia and lowers the highest and last CT scores from sequential chest CT. AJR Am J Roentgenol. 2020; 1\u20137.","DOI":"10.2214\/AJR.20.23078"},{"key":"648_CR24","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.7150\/thno.45016","volume":"10","author":"W Zhao","year":"2020","unstructured":"Zhao W, Zhong Z, Xie X, et al. CT scans of patients with 2019 novel coronavirus (COVID-19) pneumonia. Theranostics. 2020;10:4606\u201313.","journal-title":"Theranostics"},{"key":"648_CR25","doi-asserted-by":"crossref","unstructured":"Simpson S, Kay FU, Abbara S et al. Radiological society of north america expert consensus statement on reporting chest CT findings related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. J Thorac Imaging. 2020;35(4):219\u2013227.","DOI":"10.1097\/RTI.0000000000000524"},{"key":"648_CR26","doi-asserted-by":"crossref","unstructured":"Bai HX, Hsieh B, Xiong Z et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. 2020;296(2):E46\u2013E54.","DOI":"10.1148\/radiol.2020200823"},{"key":"648_CR27","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.crad.2020.04.001","volume":"75","author":"J Wang","year":"2020","unstructured":"Wang J, Xu Z, Wang J, et al. CT characteristics of patients infected with 2019 novel coronavirus: association with clinical type. Clin Radiol. 2020;75:408\u201314.","journal-title":"Clin Radiol"},{"key":"648_CR28","first-page":"1","volume":"2020","author":"R Han","year":"2019","unstructured":"Han R, Huang L, Jiang H, Early clinical and CT manifestations of coronavirus disease, et al. (COVID-19) Pneumonia. AJR Am J Roentgenol. 2019;2020:1\u20136.","journal-title":"AJR Am J Roentgenol"},{"key":"648_CR29","doi-asserted-by":"crossref","unstructured":"Ottestad W, Seim M, Maehlen JO. COVID-19 with silent hypoxemia. Tidsskr Nor Laegeforen. 2020; 140.","DOI":"10.4045\/tidsskr.20.0299"},{"key":"648_CR30","doi-asserted-by":"crossref","unstructured":"Gattinoni L, Coppola S, Cressoni M et al. COVID-19 does not lead to a \u201ctypical\u201d acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;201(10):1299\u20131300.","DOI":"10.1164\/rccm.202003-0817LE"},{"key":"648_CR31","doi-asserted-by":"crossref","unstructured":"Gattinoni L, Chiumello D, Caironi P et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intens Care Med. 2020;46(6):1099\u20131102.","DOI":"10.1007\/s00134-020-06033-2"},{"key":"648_CR32","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1056\/NEJMoa052052","volume":"354","author":"L Gattinoni","year":"2006","unstructured":"Gattinoni L, Caironi P, Cressoni M, et al. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med. 2006;354:1775\u201386.","journal-title":"N Engl J Med"},{"key":"648_CR33","doi-asserted-by":"crossref","unstructured":"Pan C, Chen L, Lu C et al. Lung recruitability in SARS-CoV-2 associated acute respiratory distress syndrome: a single-center, observational study. Am J Respir Crit Care Med. 2020;201(10):1294\u20131297.","DOI":"10.1164\/rccm.202003-0527LE"},{"key":"648_CR34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/acem.13994","volume":"27","author":"ND Caputo","year":"2020","unstructured":"Caputo ND, Strayer RJ, Levitan R. Early self-proning in awake, non-intubated patients in the emergency department: a single ED\u2019s experience during the COVID-19 pandemic. Acad Emerg Med. 2020;27:375\u20138.","journal-title":"Acad Emerg Med"},{"key":"648_CR35","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","volume":"11","author":"D Ragab","year":"2020","unstructured":"Ragab D, Salah Eldin H, Taeimah M, et al. The COVID-19 cytokine storm; what we know so far. Front Immunol. 2020;11:1446.","journal-title":"Front Immunol"},{"key":"648_CR36","doi-asserted-by":"crossref","unstructured":"Solinas C, Perra L, Aiello M et al. A critical evaluation of glucocorticoids in the management of severe COVID-19. Cytokine growth factor Rev. 2020;S135-6101(20)30161\u20131.","DOI":"10.1016\/j.cytogfr.2020.06.012"},{"key":"648_CR37","doi-asserted-by":"publisher","unstructured":"Antony SJ, Davis MA, Davis MG et al. Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management. J Med Virol. 2020. https:\/\/doi.org\/10.1002\/jmv.26288.","DOI":"10.1002\/jmv.26288"},{"key":"648_CR38","unstructured":"Titanji BK, Farley MM, Mehta A et al. Use of Baricitinib in Patients with Moderate and Severe COVID-19. Clin Infect Dis. 2020;ciaa879."},{"key":"648_CR39","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.22.20137273","author":"P Horby","year":"2020","unstructured":"Horby P, Lim W, Emberson J, et al. Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.06.22.20137273.","journal-title":"medRxiv"},{"key":"648_CR40","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506.","journal-title":"Lancet"},{"key":"648_CR41","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054\u201362.","journal-title":"Lancet"},{"key":"648_CR42","doi-asserted-by":"crossref","unstructured":"Wu C, Chen X, Cai Y et al. Risk Factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"648_CR43","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708\u201320.","journal-title":"N Engl J Med"},{"key":"648_CR44","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846\u20138.","journal-title":"Intensive Care Med"},{"key":"648_CR45","doi-asserted-by":"crossref","first-page":"e0008280","DOI":"10.1371\/journal.pntd.0008280","volume":"14","author":"R Huang","year":"2020","unstructured":"Huang R, Zhu L, Xue L, et al. Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center study. PLoS Negl Trop Dis. 2020;14:e0008280.","journal-title":"PLoS Negl Trop Dis"},{"key":"648_CR46","doi-asserted-by":"crossref","unstructured":"Wang W, Xu Y, Gao R et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843\u20131844.","DOI":"10.1001\/jama.2020.3786"},{"key":"648_CR47","doi-asserted-by":"crossref","unstructured":"Guan WJ, Liang WH, Zhao Y et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547.","DOI":"10.1183\/13993003.01227-2020"},{"key":"648_CR48","doi-asserted-by":"crossref","unstructured":"Zhang JJ, Dong X, Cao YY et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730\u20131741.","DOI":"10.1111\/all.14238"},{"key":"648_CR49","doi-asserted-by":"crossref","unstructured":"Richardson S, Hirsch JS, Narasimhan M et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052\u20132059.","DOI":"10.1001\/jama.2020.6775"},{"key":"648_CR50","doi-asserted-by":"crossref","unstructured":"Wang D, Hu B, Hu C et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061\u20131069.","DOI":"10.1001\/jama.2020.1585"},{"key":"648_CR51","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475\u201381.","journal-title":"Lancet Respir Med"},{"key":"648_CR52","doi-asserted-by":"crossref","unstructured":"Guo T, Fan Y, Chen M et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):1\u20138.","DOI":"10.1001\/jamacardio.2020.1017"},{"key":"648_CR53","doi-asserted-by":"crossref","first-page":"m1091","DOI":"10.1136\/bmj.m1091","volume":"368","author":"T Chen","year":"2020","unstructured":"Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091.","journal-title":"BMJ"},{"key":"648_CR54","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jinf.2020.03.041","volume":"80","author":"L Fu","year":"2020","unstructured":"Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect. 2020;80:656\u201365.","journal-title":"J Infect"},{"key":"648_CR55","doi-asserted-by":"crossref","unstructured":"Sanchis-Gomar F, Lavie C, Mehra M et al. Obesity and outcomes in COVID-19: when an epidemic and pandemic collide. Mayo Clinic Proc. 2020; (in press)","DOI":"10.1016\/j.mayocp.2020.05.006"},{"key":"648_CR56","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.peptides.2005.01.009","volume":"26","author":"F Gembardt","year":"2005","unstructured":"Gembardt F, Sterner-Kock A, Imboden H, et al. Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. Peptides. 2005;26:1270\u20137.","journal-title":"Peptides"},{"key":"648_CR57","doi-asserted-by":"crossref","unstructured":"Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2020;ehaa190.","DOI":"10.1093\/eurheartj\/ehaa190"},{"key":"648_CR58","doi-asserted-by":"crossref","unstructured":"Zeng JH, Liu YX, Yuan J et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020;1\u20135.","DOI":"10.20944\/preprints202003.0180.v1"},{"key":"648_CR59","doi-asserted-by":"crossref","unstructured":"Inciardi RM, Lupi L, Zaccone G et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;174:30\u201333.","DOI":"10.1001\/jamacardio.2020.1096"},{"key":"648_CR60","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/S0140-6736(20)30912-0","volume":"395","author":"D Doyen","year":"2020","unstructured":"Doyen D, Moceri P, Ducreux D, Dellamonica J. Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes. Lancet. 2020;395:1516.","journal-title":"Lancet"},{"key":"648_CR61","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","volume":"118","author":"VB Patel","year":"2016","unstructured":"Patel VB, Zhong JC, Grant MB, Oudit GY. Role of the ACE2\/angiotensin 1-7 axis of the renin-angiotensin system in heart failure. Circ Res. 2016;118:1313\u201326.","journal-title":"Circ Res"},{"key":"648_CR62","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","volume":"11","author":"F Jiang","year":"2014","unstructured":"Jiang F, Yang J, Zhang Y, et al. Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets. Nat Rev Cardiol. 2014;11:413\u201326.","journal-title":"Nat Rev Cardiol"},{"key":"648_CR63","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.biochi.2020.04.008","volume":"174","author":"M Alifano","year":"2020","unstructured":"Alifano M, Alifano P, Forgez P, Iannelli A. Renin-angiotensin system at the heart of COVID-19 pandemic. Biochimie. 2020;174:30\u20133.","journal-title":"Biochimie"},{"key":"648_CR64","doi-asserted-by":"crossref","unstructured":"Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020;76:14\u201320.","DOI":"10.1016\/j.ejim.2020.04.037"},{"key":"648_CR65","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","volume":"318","author":"AM South","year":"2020","unstructured":"South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol. 2020;318:H1084\u201390.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"648_CR66","doi-asserted-by":"crossref","unstructured":"Qin C, Zhou L, Hu Z et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020;ciaa248.","DOI":"10.1093\/cid\/ciaa248"},{"key":"648_CR67","doi-asserted-by":"crossref","unstructured":"Bonow RO, Fonarow GC, O\u2019Gara PT, Yancy CW. Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 2020.","DOI":"10.1001\/jamacardio.2020.1105"},{"key":"648_CR68","doi-asserted-by":"publisher","unstructured":"Libby P. The Heart in COVID19: primary target or secondary bystander? JACC Basic Transl Sci. 2020;5(5):537\u2013542. https:\/\/doi.org\/10.1016\/j.jacbts.2020.04.001.","DOI":"10.1016\/j.jacbts.2020.04.001"},{"key":"648_CR69","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417\u20138.","journal-title":"Lancet"},{"key":"648_CR70","doi-asserted-by":"publisher","unstructured":"Han H, Xie L, Liu R et al. Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China. J Med Virol. 2020;92(7):819\u2013823. https:\/\/doi.org\/10.1002\/jmv.25809","DOI":"10.1002\/jmv.25809"},{"key":"648_CR71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJMra1808137","volume":"380","author":"DM Musher","year":"2019","unstructured":"Musher DM, Abers MS, Corrales-Medina VF. Acute Infection and Myocardial Infarction. N Engl J Med. 2019;380:171\u20136.","journal-title":"N Engl J Med"},{"key":"648_CR72","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0735-1097(00)00690-2","volume":"36","author":"GM Felker","year":"2000","unstructured":"Felker GM, Boehmer JP, Hruban RH, et al. Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol. 2000;36:227\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"648_CR73","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/CIRCULATIONAHA.118.035319","volume":"138","author":"E Ammirati","year":"2018","unstructured":"Ammirati E, Cipriani M, Moro C, et al. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: multicenter Lombardy registry. Circulation. 2018;138:1088\u201399.","journal-title":"Circulation"},{"key":"648_CR74","doi-asserted-by":"publisher","unstructured":"Gautret P, Lagier JC, Parola P et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020;105949. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105949.","DOI":"10.1016\/j.ijantimicag.2020.105949"},{"key":"648_CR75","doi-asserted-by":"crossref","unstructured":"Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ. Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19). Mayo Clin Proc 2020;95(6):1213\u20131221.","DOI":"10.1016\/j.mayocp.2020.03.024"},{"key":"648_CR76","doi-asserted-by":"crossref","unstructured":"Viner RM, Whittaker E. Kawasaki-like disease: emerging complication during the COVID-19 pandemic. Lancet 2020.","DOI":"10.1016\/S0140-6736(20)31129-6"},{"key":"648_CR77","doi-asserted-by":"publisher","unstructured":"Verdoni L, Mazza A, Gervasoni A et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020. https:\/\/doi.org\/10.1016\/S0140-6736(20)31103-X.","DOI":"10.1016\/S0140-6736(20)31103-X"},{"key":"648_CR78","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/gutjnl-2020-320832","volume":"69","author":"W Liang","year":"2020","unstructured":"Liang W, Feng Z, Rao S, et al. Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut. 2020;69:1141\u20133.","journal-title":"Gut"},{"key":"648_CR79","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/gutjnl-2020-321051","volume":"69","author":"J Ong","year":"2020","unstructured":"Ong J, Young BE, Ong S. COVID-19 in gastroenterology: a clinical perspective. Gut. 2020;69:1144\u20135.","journal-title":"Gut"},{"key":"648_CR80","doi-asserted-by":"crossref","unstructured":"Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun 2020; 135\u2013140.","DOI":"10.1016\/j.bbrc.2020.02.071"},{"key":"648_CR81","doi-asserted-by":"crossref","unstructured":"Luo S, Zhang X, Xu H. Don\u2019t overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19). Clin Gastroenterol Hepatol 2020.","DOI":"10.1016\/j.cgh.2020.03.043"},{"key":"648_CR82","doi-asserted-by":"crossref","first-page":"766","DOI":"10.14309\/ajg.0000000000000620","volume":"115","author":"L Pan","year":"2020","unstructured":"Pan L, Mu M, Yang P, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020;115:766\u201373.","journal-title":"Am J Gastroenterol"},{"key":"648_CR83","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/gutjnl-2020-320926","volume":"69","author":"X Jin","year":"2020","unstructured":"Jin X, Lian JS, Hu JH, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69:1002\u20139.","journal-title":"Gut"},{"key":"648_CR84","doi-asserted-by":"crossref","first-page":"790","DOI":"10.14309\/ajg.0000000000000610","volume":"115","author":"L Chen","year":"2020","unstructured":"Chen L, Lou J, Bai Y, Wang M. COVID-19 Disease With Positive Fecal and Negative Pharyngeal and Sputum Viral Tests. Am J Gastroenterol. 2020;115:790.","journal-title":"Am J Gastroenterol"},{"key":"648_CR85","doi-asserted-by":"publisher","unstructured":"Young BE, Ong SWX, Kalimuddin S et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 2020;.23(15):1488\u20131494. https:\/\/doi.org\/10.1001\/jama.2020.3204.","DOI":"10.1001\/jama.2020.3204"},{"key":"648_CR86","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/CM9.0000000000000774","volume":"133","author":"Y Ling","year":"2020","unstructured":"Ling Y, Xu SB, Lin YX, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl). 2020;133:1039\u201343.","journal-title":"Chin Med J (Engl)"},{"key":"648_CR87","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507\u201313.","journal-title":"Lancet"},{"key":"648_CR88","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","volume":"20","author":"H Shi","year":"2020","unstructured":"Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20:425\u201334.","journal-title":"Lancet Infect Dis"},{"key":"648_CR89","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","volume":"5","author":"C Zhang","year":"2020","unstructured":"Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5:428\u201330.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"648_CR90","doi-asserted-by":"crossref","first-page":"m606","DOI":"10.1136\/bmj.m606","volume":"368","author":"XW Xu","year":"2020","unstructured":"Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606.","journal-title":"BMJ"},{"key":"648_CR91","doi-asserted-by":"crossref","unstructured":"Yao X, Ye F, Zhang M et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020;ciaa237.","DOI":"10.1093\/cid\/ciaa237"},{"key":"648_CR92","doi-asserted-by":"crossref","unstructured":"Mao R, Qiu Y, He JS et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020;5(7):66\u2013678.","DOI":"10.1016\/S2468-1253(20)30126-6"},{"key":"648_CR93","doi-asserted-by":"publisher","unstructured":"Terpos E, Ntanasis-Stathopoulos I, Elalamy I et al. Hematological findings and complications of COVID-19. Am J Hematol 2020;95(7):834\u2013847. https:\/\/doi.org\/10.1002\/ajh.25829.","DOI":"10.1002\/ajh.25829"},{"key":"648_CR94","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/22221751.2020.1741327","volume":"9","author":"T Li","year":"2020","unstructured":"Li T, Lu H, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect. 2020;9:687\u201390.","journal-title":"Emerg Microbes Infect"},{"key":"648_CR95","doi-asserted-by":"crossref","first-page":"e98020","DOI":"10.1371\/journal.pone.0098020","volume":"9","author":"S Singh","year":"2014","unstructured":"Singh S, Sharma A, Arora SK. High producer haplotype (CAG) of -863C\/A, -308G\/A and -238G\/A polymorphisms in the promoter region of TNF-alpha gene associate with enhanced apoptosis of lymphocytes in HIV-1 subtype C infected individuals from North India. PLoS ONE. 2014;9:e98020.","journal-title":"PLoS ONE"},{"key":"648_CR96","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.4049\/jimmunol.169.8.4288","volume":"169","author":"YC Liao","year":"2002","unstructured":"Liao YC, Liang WG, Chen FW, et al. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J Immunol. 2002;169:4288\u201397.","journal-title":"J Immunol"},{"key":"648_CR97","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.4049\/jimmunol.162.4.2154","volume":"162","author":"S Aggarwal","year":"1999","unstructured":"Aggarwal S, Gollapudi S, Gupta S. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. J Immunol. 1999;162:2154\u201361.","journal-title":"J Immunol"},{"key":"648_CR98","doi-asserted-by":"publisher","unstructured":"Chan JF, Zhang AJ, Yuan S et al. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin Infect Dis 2020;ciaa325. https:\/\/doi.org\/10.1093\/cid\/ciaa325.","DOI":"10.1093\/cid\/ciaa325"},{"key":"648_CR99","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","volume":"506","author":"G Lippi","year":"2020","unstructured":"Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145\u20138.","journal-title":"Clin Chim Acta"},{"key":"648_CR100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cca.2020.03.004","volume":"505","author":"G Lippi","year":"2020","unstructured":"Lippi G, Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chim Acta. 2020;505:190\u20131.","journal-title":"Clin Chim Acta"},{"key":"648_CR101","doi-asserted-by":"publisher","unstructured":"Tan T, Khoo B, Mills EG et al. Association between high serum total cortisol concentrations and mortality from COVID-19. Lancet Diabetes Endocrinol. 2020;8(8):659\u2013660. https:\/\/doi.org\/10.1016\/S2213-8587(20)30216-3.","DOI":"10.1016\/S2213-8587(20)30216-3"},{"key":"648_CR102","doi-asserted-by":"crossref","unstructured":"Deng Y, Liu W, Liu K et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020;133(11):1261\u20131267.","DOI":"10.1097\/CM9.0000000000000824"},{"key":"648_CR103","doi-asserted-by":"publisher","unstructured":"Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438\u2013e440. https:\/\/doi.org\/10.1016\/S2352-3026(20)30145-9.","DOI":"10.1016\/S2352-3026(20)30145-9"},{"key":"648_CR104","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ejim.2011.10.019","volume":"23","author":"D Snijders","year":"2012","unstructured":"Snijders D, Schoorl M, Schoorl M, et al. D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial. Eur J Intern Med. 2012;23:436\u201341.","journal-title":"Eur J Intern Med"},{"key":"648_CR105","doi-asserted-by":"crossref","unstructured":"Shi S, Qin M, Shen B et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020.","DOI":"10.1001\/jamacardio.2020.0950"},{"key":"648_CR106","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844\u20137.","journal-title":"J Thromb Haemost"},{"key":"648_CR107","doi-asserted-by":"crossref","unstructured":"Bloch EM, Shoham S, Casadevall A et al. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest 2020;130(6):2757\u20132765.","DOI":"10.1172\/JCI138745"},{"key":"648_CR108","doi-asserted-by":"publisher","unstructured":"Lippi G, Favaloro EJ. D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thromb Haemost 2020;120(5):87\u2013878. https:\/\/doi.org\/10.1055\/s-0040-1709650.","DOI":"10.1055\/s-0040-1709650"},{"key":"648_CR109","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/jth.14781","volume":"18","author":"D Lillicrap","year":"2020","unstructured":"Lillicrap D. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J Thromb Haemost. 2020;18:786\u20137.","journal-title":"J Thromb Haemost"},{"key":"648_CR110","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","volume":"141","author":"SR Kahn","year":"2012","unstructured":"Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e195S\u2013226S.","journal-title":"Chest"},{"key":"648_CR111","doi-asserted-by":"crossref","unstructured":"Tang N, Bai H, Chen X et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094\u20131099.","DOI":"10.1111\/jth.14817"},{"key":"648_CR112","doi-asserted-by":"publisher","unstructured":"Thachil J, Tang N, Gando S et al. ISTH interim guidance on recognition and management of coagulopathy in COVID\u201019. J Thromb Haemost. 2020. https:\/\/doi.org\/10.1111\/jth.14810.","DOI":"10.1111\/jth.14810"},{"key":"648_CR113","doi-asserted-by":"crossref","unstructured":"Needham EJ, Chou SH, Coles AJ, Menon DK. Neurological implications of COVID-19 infections. Neurocrit Care. 2020;32:667\u2013671.","DOI":"10.1007\/s12028-020-00978-4"},{"key":"648_CR114","doi-asserted-by":"publisher","unstructured":"Mao L, Jin H, Wang M et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):1\u20139. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1127.","DOI":"10.1001\/jamaneurol.2020.1127"},{"key":"648_CR115","doi-asserted-by":"publisher","unstructured":"Helms J, Kremer S, Merdji H et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020;382:2268\u20132270. https:\/\/doi.org\/10.1056\/NEJMc2008597.","DOI":"10.1056\/NEJMc2008597"},{"key":"648_CR116","doi-asserted-by":"crossref","first-page":"175628642093203","DOI":"10.1177\/1756286420932036","volume":"13","author":"G Tsivgoulis","year":"2020","unstructured":"Tsivgoulis G, Palaiodimou L, Katsanos AH, et al. Neurological manifestations and implications of COVID-19 pandemic. Ther Adv Neurol Disord. 2020;13:1756286420932036.","journal-title":"Ther Adv Neurol Disord"},{"key":"648_CR117","doi-asserted-by":"crossref","unstructured":"Zubair AS, McAlpine LS, Gardin T et al. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: A Review. JAMA Neurol 2020.","DOI":"10.1001\/jamaneurol.2020.2065"},{"key":"648_CR118","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1212\/WNL.0000000000009455","volume":"94","author":"A Nath","year":"2020","unstructured":"Nath A. Neurologic complications of coronavirus infections. Neurology. 2020;94:809\u201310.","journal-title":"Neurology"},{"key":"648_CR119","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631\u20137.","journal-title":"J Pathol"},{"key":"648_CR120","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/med.21343","volume":"35","author":"C Cabello-Verrugio","year":"2015","unstructured":"Cabello-Verrugio C, Morales MG, Rivera JC, et al. Renin-angiotensin system: an old player with novel functions in skeletal muscle. Med Res Rev. 2015;35:437\u201363.","journal-title":"Med Res Rev"},{"key":"648_CR121","doi-asserted-by":"crossref","unstructured":"Poyiadji N, Shahin G, Noujaim D et al. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020; 201187.","DOI":"10.1148\/radiol.2020201187"},{"key":"648_CR122","doi-asserted-by":"crossref","unstructured":"Toscano G, Palmerini F, Ravaglia S et al. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2. New Engl J Med. 2020; NEJMc2009191.","DOI":"10.1056\/NEJMc2009191"},{"key":"648_CR123","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","volume":"19","author":"H Zhao","year":"2020","unstructured":"Zhao H, Shen D, Zhou H, et al. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19:383\u20134.","journal-title":"Lancet Neurol"},{"key":"648_CR124","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00134-020-05944-4","volume":"46","author":"I Vanhorebeek","year":"2020","unstructured":"Vanhorebeek I, Latronico N, Van den Berghe G. ICU-acquired weakness. Intensive Care Med. 2020;46:637\u201353.","journal-title":"Intensive Care Med"},{"key":"648_CR125","doi-asserted-by":"crossref","unstructured":"Kansagra AP, Goyal MS, Hamilton S, Albers GW. Collateral effect of COVID-19 on stroke evaluation in the United States. New Engl J Med. 2020.","DOI":"10.1056\/NEJMc2014816"},{"key":"648_CR126","doi-asserted-by":"crossref","unstructured":"Yaghi S, Ishida K, Torres J et al. SARS2-CoV-2 and stroke in a new york healthcare system. Stroke 2020; Strokeaha120030335.","DOI":"10.1161\/STROKEAHA.120.031606"},{"key":"648_CR127","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.031208","author":"G Ntaios","year":"2020","unstructured":"Ntaios G, Michel P, Georgiopoulos G, et al. Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke. The global COVID-19 stroke registry. Stroke. 2020. https:\/\/doi.org\/10.1161\/STROKEAHA.120.031208.","journal-title":"Stroke"},{"key":"648_CR128","doi-asserted-by":"crossref","unstructured":"Bikdeli B, Madhavan MV, Jimenez D et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020.","DOI":"10.1016\/j.jacc.2020.04.031"},{"key":"648_CR129","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1056\/NEJMc2009787","volume":"382","author":"TJ Oxley","year":"2020","unstructured":"Oxley TJ, Mocco J, Majidi S, et al. Large-vessel stroke as a presenting feature of COVID-19 in the young. N Engl J Med. 2020;382:e60.","journal-title":"N Engl J Med"},{"key":"648_CR130","unstructured":"Lechien JR, Chiesa-Estomba CM, De Siati DR et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020; 1\u201311."},{"key":"648_CR131","doi-asserted-by":"crossref","unstructured":"Speth MM, Singer-Cornelius T, Obere M et al. Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics. Otolaryngol Head Neck Surg. 2020; 194599820929185.","DOI":"10.1177\/0194599820929185"},{"key":"648_CR132","doi-asserted-by":"crossref","unstructured":"Tsivgoulis G, Fragkou PC, Delides A et al. Quantitative evaluation of olfactory dysfunction in hospitalized patients with Coronavirus [2] (COVID-19). J Neurol 2020; 1-3.","DOI":"10.1007\/s00415-020-09935-9"},{"key":"648_CR133","doi-asserted-by":"crossref","unstructured":"Vaira LA, Hopkins C, Salzano G et al. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study. Head Neck 2020.","DOI":"10.1002\/hed.26269"},{"key":"648_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.wjorl.2020.1004.1001","author":"WP Lao","year":"2020","unstructured":"Lao WP, Imam SA, Nguyen SA. Anosmia, hyposmia, and dysgeusia as indicators for positive SARS-CoV-2 infection. World journal of otorhinolaryngology - head and neck surgery. 2020. https:\/\/doi.org\/10.1016\/j.wjorl.2020.1004.1001.","journal-title":"World journal of otorhinolaryngology - head and neck surgery"},{"key":"648_CR135","unstructured":"Giacomelli A, Pezzati L, Conti F et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis 2020."},{"key":"648_CR136","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","volume":"11","author":"AM Baig","year":"2020","unstructured":"Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11:995\u20138.","journal-title":"ACS Chem Neurosci"},{"key":"648_CR137","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","volume":"97","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97:829\u201338.","journal-title":"Kidney Int"},{"key":"648_CR138","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20050828","volume":"202","author":"J Gu","year":"2005","unstructured":"Gu J, Gong E, Zhang B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202:415\u201324.","journal-title":"J Exp Med"},{"key":"648_CR139","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ki.2015.320","volume":"89","author":"R Rodriguez-Romo","year":"2016","unstructured":"Rodriguez-Romo R, Benitez K, Barrera-Chimal J, et al. AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease. Kidney Int. 2016;89:363\u201373.","journal-title":"Kidney Int"},{"key":"648_CR140","unstructured":"Boulware DR, Pullen MF, Bangdiwala AS et al. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for COVID-19. N Engl J Med 2020."},{"key":"648_CR141","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/path.1560","volume":"203","author":"Y Ding","year":"2004","unstructured":"Ding Y, He L, Zhang Q, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004;203:622\u201330.","journal-title":"J Pathol"},{"key":"648_CR142","doi-asserted-by":"publisher","unstructured":"Guarneri C, Rullo EV, Pavone P et al. Silent COVID-19: what your skin can reveal. Lancet Infect Dis. 2020. https:\/\/doi.org\/10.1016\/S1473-3099(20)30402-3.","DOI":"10.1016\/S1473-3099(20)30402-3"},{"key":"648_CR143","doi-asserted-by":"publisher","unstructured":"Madigan LM, Micheletti RG, Shinkai K. How dermatologists can learn and contribute at the leading edge of the COVID-19 global pandemic. JAMA Dermatol. 2020. https:\/\/doi.org\/10.1001\/jamadermatol.2020.1438.","DOI":"10.1001\/jamadermatol.2020.1438"},{"key":"648_CR144","doi-asserted-by":"publisher","unstructured":"Sanchez A, Sohier P, Benghanem S et al. Digitate papulosquamous eruption associated with severe acute respiratory syndrome coronavirus 2 infection. JAMA Dermatol. 2020. https:\/\/doi.org\/10.1001\/jamadermatol.2020.1704.","DOI":"10.1001\/jamadermatol.2020.1704"},{"key":"648_CR145","doi-asserted-by":"publisher","unstructured":"Diaz-Guimaraens B, Dominguez-Santas M, Suarez-Valle A et al. Petechial skin rash associated with severe acute respiratory syndrome coronavirus 2 infection. JAMA Dermatol. 2020. https:\/\/doi.org\/10.1001\/jamadermatol.2020.1741.","DOI":"10.1001\/jamadermatol.2020.1741"},{"key":"648_CR146","doi-asserted-by":"publisher","unstructured":"Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;;34(5):e21\u2013e213. https:\/\/doi.org\/10.1111\/jdv.16387.","DOI":"10.1111\/jdv.16387"},{"key":"648_CR147","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.mehy.2004.04.009","volume":"63","author":"R Wheatland","year":"2004","unstructured":"Wheatland R. Molecular mimicry of ACTH in SARS\u2014implications for corticosteroid treatment and prophylaxis. Med Hypotheses. 2004;63:855\u201362.","journal-title":"Med Hypotheses"},{"key":"648_CR148","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2265.2005.02325.x","volume":"63","author":"MK Leow","year":"2005","unstructured":"Leow MK, Kwek DS, Ng AW, et al. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf). 2005;63:197\u2013202.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"648_CR149","doi-asserted-by":"publisher","unstructured":"Pal R. COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications. Endocrine 2020;28:1\u20132. https:\/\/doi.org\/10.1007\/s12020-020-02325-1.","DOI":"10.1007\/s12020-020-02325-1"},{"key":"648_CR150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/09273948.2020.1738501","volume":"28","author":"I Seah","year":"2020","unstructured":"Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28:391\u20135.","journal-title":"Ocul Immunol Inflamm"},{"key":"648_CR151","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra032498","volume":"349","author":"JSM Peiris","year":"2003","unstructured":"Peiris JSM, Yuen KY, Osterhaus ADME, St\u00f6hr K. The severe acute respiratory syndrome. N Engl J Med. 2003;349:2431\u201341.","journal-title":"N Engl J Med"},{"key":"648_CR152","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaophthalmol.2020.1291","volume":"138","author":"P Wu","year":"2020","unstructured":"Wu P, Duan F, Luo C, et al. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138:575\u20138.","journal-title":"JAMA Ophthalmol"},{"key":"648_CR153","doi-asserted-by":"crossref","unstructured":"Marinho PM, Marcos AA, Romano AC et al. Retinal findings in patients with COVID-19. Lancet 2020; (online first).","DOI":"10.1016\/S0140-6736(20)31014-X"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-020-00648-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-020-00648-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-020-00648-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T22:12:29Z","timestamp":1696457549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-020-00648-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,27]]},"references-count":153,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["648"],"URL":"https:\/\/doi.org\/10.1007\/s10238-020-00648-x","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,27]]},"assertion":[{"value":"3 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no relevant conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}